medroxyprogesterone acetate has been researched along with Reperfusion Injury in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Booth, EA; Lucchesi, BR | 1 |
1 other study(ies) available for medroxyprogesterone acetate and Reperfusion Injury
| Article | Year |
|---|---|
Medroxyprogesterone acetate prevents the cardioprotective and anti-inflammatory effects of 17beta-estradiol in an in vivo model of myocardial ischemia and reperfusion.
Topics: Animals; Antineoplastic Agents, Hormonal; Blood Pressure; Disease Models, Animal; Drug Interactions; Estradiol; Heart; Heart Rate; Male; Malondialdehyde; Medroxyprogesterone Acetate; Myocardial Infarction; Myocardial Reperfusion Injury; Rabbits; Reperfusion Injury; Troponin I | 2007 |